Compare Adaptive Biotechnologies Corp (ADPT) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Lockheed Martin Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Lockheed Martin Corporation trades at $528.11 (market cap $123.44B). The key difference: Lockheed Martin Corporation is far larger — about 37.1× Adaptive Biotechnologies Corp's market cap, and Lockheed Martin Corporation pays a 2.58% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LMT | |
|---|---|---|
Market Cap | $3.33B | $123.44B |
Sector | Health | Industrials |
52-Week High | $22.37 | $676.70 |
52-Week Low | $10.24 | $410.74 |
Enterprise Value | $3.19B | $142.24B |
Dividend Yield | — | 2.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
